Entries of Hildebrandt, Martin on the publication server

Multhoff, Gabriele, Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim , Werner, Caroline, Pockley, A. Graham , Blankenstein, Christiane, Hildebrandt, Martin, Offner, Robert, Ahrens, Norbert, Kokowski, Konrad, Hautmann, Matthias, Rödel, Claus, Fietkau, Rainer, Lubgan, Dorota, Huber, Rudolf , Hautmann, Hubert, Duell, Thomas, Molls, Michael, Specht, Hanno, Haller, Bernhard, Devecka, Michal, Sauter, Andreas and Combs, Stephanie E. (2020) Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial. Clinical Cancer Research 26 (20), pp. 5368-5379. Fulltext not available.

Multhoff, Gabriele, Combs, Stephanie E., Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim , Blankenstein, Christiane, Hildebrandt, Martin, Kokowski, Konrad, Hautmann, Matthias, Hautmann, Hubert, Rödel, Claus, Fietkau, Rainer, Huber, Rudolf , Haller, Bernhard, Ertl, Christine, Devecka, Michal, Offner, Robert and Ahrens, Norbert (2020) Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30). Cancer research 80 (16supp). Fulltext not available.